Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedThe EMERALD study record is displayed, describing elacestrant versus standard-of-care treatment, eligibility criteria, study arms and outcomes, participating locations, and record history. It also provides related publications and study documents; the trial is completed and no longer recruiting.SummaryDifference100%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide notice announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” across its content.SummaryDifference1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study content, with a 403 header and a Home link. This indicates access to the study record is blocked.SummaryDifference17%

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.